View More Recent Stories

Sep 19, 2024 02:44AM JPMorgan Downgrades Halozyme Therapeutics (HALO) to Neutral

Sep 16, 2024 07:00AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

Sep 13, 2024 01:31PM Halozyme Therapeutics (HALO) Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO with ENHANZE

Sep 13, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

Aug 7, 2024 10:25AM Halozyme Therapeutics (HALO) PT Raised to $65 at TD Cowen

Aug 6, 2024 04:40PM Halozyme Therapeutics (HALO) Tops Q2 EPS by 15c ; Offers Guidance

Jul 16, 2024 10:51AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

Jun 27, 2024 06:37AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

Jun 25, 2024 07:39AM Halozyme Therapeutics (HALO) PT Raised to $60 at Benchmark

Jun 24, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

View More Recent Stories